Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
koltjäreextrakt 2 %, schampo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Selenium sulfide 25 mg/mL shampoo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
alkoholhaltigt koltjäreextrakt 5 %, schampo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Coal tar 43 mg/mL shampoo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Lithium succinate 80 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely lithium succinate 80 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
kloramfenikol 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
kolistinsulfat, pulver för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Mupirocin (as mupirocin calcium) 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Neomycin 0.5% cream BPC |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Silver sulfadiazine 1% cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Fusidic acid 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Sodium fusidate 20 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
betametason 0,05 % + klotrimazol 1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely clotrimazole 10 milligram/1 milliliter conventional release cutaneous spray (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klotrimazol 1 %, puder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Econazole nitrate 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Ketoconazole 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Miconazole nitrate 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
mikonazolnitrat 2 %, puder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Sulconazole nitrate 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Undecylenic acid 50 mg/mL and zinc undecylenate 200 mg/mL cutaneous spray |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Metronidazole 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
amorolfin 5 %, nagellack |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely aciclovir 50 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Penciclovir 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Benzyl benzoate 25% application BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
karbaryl 0,5 %, alkoholhaltig lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
malation 1 %, krämschampo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
malation 0,5 %, alkohollösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
malation 0,5 %, vätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Malathion 10 mg/mL shampoo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
fenotrin 0,5 %, vätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely phenothrin 5 milligram/1 gram conventional release cutaneous foam (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
permetrin 1 %, för applicering i hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Chlorhexidine 5% cream BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Proflavine cream BPC |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Povidone iodine 50 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Dibrompropamidine isetionate 1.5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Polynoxylin 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Magnesium sulfate paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Povidone iodine 100 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Aluminium acetate 6.5 mg/mL cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Cetrimide 10 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
stark cetrimidlösning 20 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
stark cetrimidlösning 40 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klorhexidinacetat 1 %, puder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
cetrimid 5 milligram/milliliter och klorhexidinglukonat (som klorhexidin) 500 mikrogram/milliliter, kutan lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klorhexidinglukonat 1,5 % + cetrimid 15 %, engångspåse med vätska för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
klorhexidinglukonat 0,015 % + cetrimid 0,15 %, engångspåse med vätska för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
stark natriumkloritlösning 8 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
svag natriumhypokloritlösning 1 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
natriumhypoklorit, engångspåse med vätska för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Brilliant green+crystal violet 0.5%/0.5% paint BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Crystal violet 0.5% paint BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Methylrosanilinium chloride 10 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Hydrogen peroxide 6%(20volume) solution BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Hydrogen peroxide 12%(40volume) solution BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Hydrogen peroxide 30%(100volume) solution BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 1,14 %, pulversprej |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 7.5 %, för kirurgisk desinfektion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 4 %, lösing för hudrengöring |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 2,5 %, pulversprej |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 10 %, antiseptisk lösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 10 %, alkohollösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
joderad povidon 10 %, preparat för pensling |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Silver nitrate 0.5% lotion BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Silver nitrate 250 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Product containing precisely silver nitrate 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
Silver nitrate 500 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|